Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid.
Shields
K G
KG
Headache Group, Institute of Neurology and The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Levy
M J
MJ
Goadsby
P J
PJ
D000273:Adipose Tissue / Q000187:drug effects / Q000473:pathology; D000328:Adult; D000505:Alopecia / Q000139:chemically induced*; D000772:Anesthesia, Local / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects; D001284:Atrophy; D005260:Female; D020773:Headache Disorders / Q000628:therapy; D006801:Humans; D007267:Injections; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000077555:Methylprednisolone Acetate; D008875:Middle Aged; D020326:Migraine without Aura / Q000628:therapy; D009407:Nerve Block / Q000009:adverse effects*; D012867:Skin / Q000187:drug effects / Q000473:pathology*
D000779:Anesthetics, Local; D000077555:Methylprednisolone Acetate; D008012:Lidocaine; D008775:Methylprednisolone